Senior analyst Pablo Zuanic hosted a fireside chat Monday evening with Jon Levine, CEO of MariMed Inc. (OTC: MRMD) who outlined the company’s operations, growth strategies and financial outlook. The discussion provided insights into MariMed’s performance in key states as well as expansion plans and future projections, offering valuable information for cannabis investors. Strong Q2 Results And Financial ProjectionsLevine noted MariMed’s robust performance in the second quarter of 2024, maintaining a year-over-year sales growth guidance of 5% to 7%. Despite industry-wide pressures, MariMed has a…
